XML 34 R15.htm IDEA: XBRL DOCUMENT
v3.25.3

Capital Stock | 9 Months Ended
--- | ---
Nov. 30, 2025
Equity [Abstract] |
Capital Stock | CAPITAL STOCK The following details the changes in issued and outstanding common shares for the nine months ended November 30, 2025:
| Capital Stock and Additional Paid-in Capital
| Stock Outstanding (000s) |  | Amount
Common shares outstanding as at February 28, 2025 | 596,231 |  |  | $ | 2,976.4 |
Exercise of stock options | 28 |  |  | — |
Common shares issued for restricted share unit settlements | 2,115 |  |  | — |
Stock-based compensation | — |  |  | 17.7 |
Common shares issued for employee share purchase plan | 580 |  |  | 2.5 |
Share repurchase | (8,562) |  |  | (42.8) |
Common shares outstanding as at November 30, 2025 | 590,392 |  |  | 2,953.8 |
The Company had 590 million voting common shares outstanding, 16.8 million restricted share units (“RSUs”) and 1.6 million deferred shared units (“DSUs”) outstanding as at December 16, 2025. In addition, 51.5 million common shares are issuable upon conversion in full of the Notes as described in Note 6. On May 8, 2025, the Company announced that it received acceptance from the Toronto Stock Exchange with respect to a normal course issuer bid (“NCIB”) share buyback program to purchase for cancellation up to 27.9 million common shares of the Company, or approximately 4.7% of the outstanding public float at May 5, 2025. The NCIB share buyback program commenced on May 12, 2025, and will terminate on the earliest of May 11, 2026, such date as the Company may determine, or the date on which the maximum number of common shares that may be purchased under the NCIB share buyback program has been reached. The Company is not obligated to repurchase any common shares under the NCIB share buyback program. During the nine months ended November 30, 2025, the Company repurchased and settled 8.6 million common shares, at a cost of $34.0 million. The Company recorded a reduction of $42.8 million to capital stock and the amount paid below the per share paid-in capital of the common shares of $8.8 million was recorded to deficit. All common shares repurchased by the Company pursuant to the NCIB share buyback program have been canceled. The Company also repurchased 0.2 million common shares, at a cost of $1.0 million on November 28, 2025 that settled on December 1, 2025.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration